This is supported by the finding that AMPK genetic knockout donor T cells reduced GvHD severity in an MHC mismatch (C57BL/6 to BALB/c) model [103], demonstrating the independent role of AMPK in GvHD development. Here, PRKAA1 is linked to graft versus host disease.